Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study

Renal impairment may be associated with an increased risk of hematologic events (AEs) in patients undergoing treatment with trifluridine/tipiracil (FTD/TPI). This study aimed to investigate the specific types of AEs linked to renal impairment in patients with metastatic colorectal cancer (mCRC) rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiroyama, Mamiko, Fukuoka, Shota, Masuishi, Toshiki, Takashima, Atsuo, Kumekawa, Yosuke, Kajiwara, Takeshi, Yamazaki, Kentaro, Shimada, Yasuhiro, Esaki, Taito, Makiyama, Akitaka, Moriwaki, Toshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589204/
https://www.ncbi.nlm.nih.gov/pubmed/37863951
http://dx.doi.org/10.1038/s41598-023-45244-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589204/
https://www.ncbi.nlm.nih.gov/pubmed/37863951
http://dx.doi.org/10.1038/s41598-023-45244-7

Ejemplares similares